SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-014032
Filing Date
2021-06-10
Accepted
2021-06-10 16:30:49
Documents
58
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 740229
2 ex10-1.htm EX-10.1 31062
3 ex10-2.htm EX-10.2 22181
4 ex31-1.htm EX-31.1 16498
5 ex31-2.htm EX-31.2 17287
6 ex32-1.htm EX-32.1 7492
7 ex32-2.htm EX-32.2 8002
  Complete submission text file 0001493152-21-014032.txt   3526112

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE anix-20210430.xml EX-101.INS 681389
9 XBRL SCHEMA FILE anix-20210430.xsd EX-101.SCH 30526
10 XBRL CALCULATION FILE anix-20210430_cal.xml EX-101.CAL 41198
11 XBRL DEFINITION FILE anix-20210430_def.xml EX-101.DEF 140519
12 XBRL LABEL FILE anix-20210430_lab.xml EX-101.LAB 232246
13 XBRL PRESENTATION FILE anix-20210430_pre.xml EX-101.PRE 188681
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-37492 | Film No.: 211008440
SIC: 2834 Pharmaceutical Preparations